Doron Birger has been serving as a Director of Citrine Global since September 2020. Mr. Birger currently serves as the Chairman of the Board of Directors of Intelicanna (TASE: INTL), and Matricelf (TASE: MTLF) and as a Director of Icecure Medical Ltd. (NASDAQ and TASE:ICCM), Kadimastem Ltd. (TASE:KDST), Pluristem (NASDAQ and TASE: PSTI) and Hera Med Ltd (ASX:HMD).
Mr. Birger also serves as chairman and director of several private companies in Israel in the hi-tech sector mainly in the medical device field.
From 2002 to 2007, Mr. Birger served as the Chairman of the board of directors of Given Imaging Ltd. and later on as a board member until February 2014.
Mr. Birger served as CEO of Elron Electronic Industries, Ltd. from August 2002 to April 2009. Prior to that, he held other executive positions at Elron, including President since 2001, Chief Financial Officer from 1994 to August 2002, and Corporate Secretary from 1994 to 2001.
He is a director of a variety of non-profit organizations in Israel. Mr. Birger holds a B.A. and an M.A. in economics from the Hebrew University Jerusalem. Mr. Birger is based in Israel.